In one paragraph
Texas's SB 815 bars utilization review agents from using an automated decision system to make, wholly or partly, an adverse determination (a finding that health care services are not medically necessary or appropriate, or are experimental or investigational). Such tools may still be used for administrative support or fraud detection, and the insurance commissioner may audit and inspect an agent's use of them at any time. Adverse determination notices must describe the screening criteria and review procedures used. Signed June 20, 2025; effective September 1, 2025; applies to utilization review for health benefit plans delivered, issued or renewed on or after January 1, 2026.
Plain-English summary, written with AI assistance. The official text controls.
What it means for business
Utilization review agents may not use automated decision systems to make, wholly or partly, adverse determinations for plans delivered, issued or renewed from Jan. 1, 2026 (administrative support and fraud detection uses are allowed). Notices must describe screening criteria and review procedures.
Key provisions
- A utilization review agent may not use an automated decision system to make, wholly or partly, an adverse determination (Ins. Code § 4201.156(a))
- Automated decision system: an algorithm, including one incorporating an AI system, that uses data-based analytics to make, suggest or recommend determinations, decisions, judgments or conclusions; "algorithm" and "artificial intelligence system" are also defined (§ 4201.002(1-a)-(1-c))
- "Adverse determination" now covers a utilization review agent's determination that services are not medically necessary or appropriate (previously: not medically necessary) or are experimental or investigational (§ 4201.002(1))
- Algorithms, AI systems and automated decision systems may still be used for administrative support or fraud-detection functions (§ 4201.156(c))
- The commissioner may audit and inspect a utilization review agent's use of an automated decision system for utilization review at any time (§ 4201.156(b))
- Notice of an adverse determination must include a description of and the source of the screening criteria and review procedures used as guidelines (§ 4201.303(a)(3))
- Signed by the Governor June 20, 2025 (Chapter 989); effective September 1, 2025; applies only to utilization review for health benefit plans delivered, issued for delivery or renewed on or after January 1, 2026 (earlier plans stay under prior law)
Latest legislative action
Jun 20, 2025. Signed by the Governor; effective on 9/1/25
Sponsors (showing 5 of 16)
| Name | Role |
|---|---|
| Buckingham | Primary |
| Coleman | Primary |
| Collier | Primary |
| Moody | Primary |
| Rodríguez | Primary |
Roll call votes (showing 3 of 4)
passage May 24, 2025
116 yea13 nay2 otherPassed
passage May 23, 2025
127 yea4 nay1 otherPassed
passage Mar 26, 2025
25 yea5 nayPassed
Topics and industries
Related topics
Affected industries
This page is general information, not legal advice. Summaries are AI-assisted and may contain errors; read the statute for the controlling text and talk to a lawyer about your situation. Full disclaimer · Report an error